Gilead Sciences: Improving the Safety and Efficacy of Yescarta® CAR T
June 6, 2019
0
AT ASCO Gilead Sciences and Yescarta® By Acquiring Kite Pharma Gilead Sciences(GILD) gained Kite’s CAR T technology and its FDA approved therapy Yescarta. At the ASCO 2019 two new analyses were presented from the ZUMA-1 clinical trial of Yescarta® in adult patients with relapsed or . . . This content is for paid subscribers. Please click here to subscribe or here to log in.